Rhythm Pharmaceuticals Inc (RYTM)
38.28
+0.13
(+0.34%)
USD |
NASDAQ |
Apr 26, 16:00
38.31
+0.03
(+0.08%)
After-Hours: 20:00
Rhythm Pharmaceuticals Gross Profit Margin (Quarterly): 86.66% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 86.66% |
September 30, 2023 | 89.28% |
June 30, 2023 | 88.37% |
March 31, 2023 | 87.61% |
December 31, 2022 | 88.30% |
September 30, 2022 | 88.40% |
Date | Value |
---|---|
June 30, 2022 | 95.83% |
March 31, 2022 | 84.65% |
December 31, 2021 | 87.01% |
September 30, 2021 | 78.40% |
June 30, 2021 | 50.00% |
March 31, 2021 | 88.57% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.00%
Minimum
Jun 2021
95.83%
Maximum
Jun 2022
84.42%
Average
87.96%
Median
Gross Profit Margin (Quarterly) Benchmarks
Pfizer Inc | 46.92% |
Insmed Inc | 77.96% |
Altimmune Inc | -- |
Regeneron Pharmaceuticals Inc | 84.95% |
Viking Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -89.34% |
Return on Assets | -53.53% |
Return on Invested Capital | -89.34% |
Profit Margin (Quarterly) | -171.8% |
Operating Margin (Quarterly) | -170.3% |
Return on Net Operating Assets | -631.3% |